The notice convening the extraordinary general meeting, including the agenda and the nomination committee's proposal to the matter to be dealt with, is linked* to this notification and will be sent to all shareholders with known addresses.
*New attachment from Nomination Committee
NOTICE OF EXTRAORDINARY GENERAL MEETING
INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING
PROPOSALS FROM THE NOMINATION COMMITTEE
Relevant documents referred to in the notice are made available on www.photocure.com.
For further information, please contact:
CFO Erik Dahl
Tel: +47 450 55 000
About Photocure ASA Photocure:
The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.